Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Añadir filtros

Base de datos
Tipo del documento
Intervalo de año
1.
ACS Appl Mater Interfaces ; 13(41): 48469-48477, 2021 Oct 20.
Artículo en Inglés | MEDLINE | ID: covidwho-1461961

RESUMEN

The COVID-19 pandemic highlighted the importance of developing surfaces and coatings with antiviral activity. Here, we present, for the first time, peptide-based assemblies that can kill viruses. The minimal inhibitory concentration (MIC) of the assemblies is in the range tens of micrograms per milliliter. This value is 2 orders of magnitude smaller than the MIC of metal nanoparticles. When applied on a surface, by drop casting, the peptide spherical assemblies adhere to the surface and form an antiviral coating against both RNA- and DNA-based viruses including coronavirus. Our results show that the coating reduced the number of T4 bacteriophages (DNA-based virus) by 3 log, compared with an untreated surface and 6 log, when compared with a stock solution. Importantly, we showed that this coating completely inactivated canine coronavirus (RNA-based virus). This peptide-based coating can be useful wherever sterile surfaces are needed to reduce the risk of viral transmission.


Asunto(s)
Antivirales/química , Péptidos/química , Animales , Antivirales/farmacología , Antivirales/uso terapéutico , Bacteriófagos/efectos de los fármacos , COVID-19/virología , Coronavirus/efectos de los fármacos , Coronavirus/aislamiento & purificación , Infecciones por Coronavirus/tratamiento farmacológico , Infecciones por Coronavirus/virología , Dihidroxifenilalanina/química , Enfermedades de los Perros/tratamiento farmacológico , Enfermedades de los Perros/virología , Perros , Humanos , Nanopartículas del Metal/química , Péptidos/farmacología , Péptidos/uso terapéutico , SARS-CoV-2/aislamiento & purificación , Inactivación de Virus/efectos de los fármacos , Tratamiento Farmacológico de COVID-19
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA